Patents by Inventor Eric Grant Lovett
Eric Grant Lovett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8948874Abstract: Devices and methods of use are described for identification, treatment, and/or management of heart failure and/or associated conditions. An exemplary device may include a first fluid status monitoring circuit configured to monitor a first fluid status indicator of a pulmonary fluid status associated with pulmonary edema, a second fluid status monitoring circuit configured to monitor a separate and different second fluid status indicator of a non-pulmonary fluid status, and a controller coupled to the first and second fluid status monitoring circuits, and a therapy circuit coupled to the controller. The controller is configured to use information about the first and second fluid status indicators to determine a therapy control signal to control a therapy, and the therapy circuit is configured to provide therapy in response to the therapy control signal to adjust at least one of the pulmonary fluid status or the non-pulmonary fluid status.Type: GrantFiled: December 27, 2013Date of Patent: February 3, 2015Assignee: CVRx, Inc.Inventors: Dimitrios Georgakopoulos, Eric Grant Lovett
-
Publication number: 20140277279Abstract: Methods and associated devices and algorithms for programming a therapy for an implanted baroreflex activation system are described and may include determining one or more programmable operating parameters of the therapy which do not cause a patient to experience extraneous stimulation associated with the therapy and programming the implanted baroreflex stimulation system with programmable operating parameters.Type: ApplicationFiled: March 15, 2013Publication date: September 18, 2014Inventors: Adam Cates, Eric Grant Lovett, Seth Wilks
-
Publication number: 20140163649Abstract: Devices and methods of use are described for identification, treatment, and/or management of heart failure and/or associated conditions. An exemplary device may include a first fluid status monitoring circuit configured to monitor a first fluid status indicator of a pulmonary fluid status associated with pulmonary edema, a second fluid status monitoring circuit configured to monitor a separate and different second fluid status indicator of a non-pulmonary fluid status, and a controller coupled to the first and second fluid status monitoring circuits, and a therapy circuit coupled to the controller. The controller is configured to use information about the first and second fluid status indicators to determine a therapy control signal to control a therapy, and the therapy circuit is configured to provide therapy in response to the therapy control signal to adjust at least one of the pulmonary fluid status or the non-pulmonary fluid status.Type: ApplicationFiled: December 27, 2013Publication date: June 12, 2014Applicant: CVRx, Inc.Inventors: Dimitrios Georgakopoulos, Eric Grant Lovett
-
Patent number: 8744586Abstract: Devices and methods for use of identification, treatment and/or management of heart failure and/or associated conditions. Methods may include providing a baroreflex therapy system, providing an implantable measurement device proximate a blood vessel of a patient, the implantable measurement device including a plurality of electrodes, determining an impedance of the blood vessel with the implantable measurement device over a time period of at least one cardiac cycle, generating at least one signal representative of a pressure waveform based on the impedance, activating, deactivating or otherwise modulating the baroreflex therapy system to deliver a therapy to treat heart failure based at least in part on the at least one signal representative of the pressure waveform.Type: GrantFiled: November 30, 2012Date of Patent: June 3, 2014Assignee: CVRx, Inc.Inventors: Dimitrios Georgakopoulos, Eric Grant Lovett, Nadim Yared
-
Patent number: 8700162Abstract: Devices and methods of use for identification, treatment and/or management of heart failure and/or associated conditions. An exemplary device may include a first sensor configured to monitor a parameter indicative of a fluid level in a pulmonary circulation of a patient, a second sensor configured to monitor a parameter indicative of a fluid level in a non-pulmonary circulation of a patient, and a control system coupled to the first sensor and second sensor. The control system is configured to provide a baroreflex therapy to the patient based at least in part on the parameter indicative of a fluid level in a pulmonary circulation and the parameter indicative of a fluid level in a non-pulmonary circulation. The baroreflex therapy adjusts at least one of the fluid level in the pulmonary circulation and the fluid level in the non-pulmonary circulation.Type: GrantFiled: October 8, 2012Date of Patent: April 15, 2014Assignee: CVRx, Inc.Inventors: Dimitrios Georgakopoulos, Eric Grant Lovett
-
Publication number: 20130338735Abstract: Devices and methods of use for identification, treatment and/or management of heart failure and/or associated conditions. An exemplary device may include a first sensor configured to monitor a parameter indicative of a fluid level in a pulmonary circulation of a patient, a second sensor configured to monitor a parameter indicative of a fluid level in a non-pulmonary circulation of a patient, and a control system coupled to the first sensor and second sensor. The control system is configured to provide a baroreflex therapy to the patient based at least in part on the parameter indicative of a fluid level in a pulmonary circulation and the parameter indicative of a fluid level in a non-pulmonary circulation. The baroreflex therapy adjusts at least one of the fluid level in the pulmonary circulation and the fluid level in the non-pulmonary circulation.Type: ApplicationFiled: October 8, 2012Publication date: December 19, 2013Inventors: Dimitrios Georgakopoulos, Eric Grant Lovett
-
Patent number: 8600511Abstract: Devices and methods of use are described for identification, treatment, and/or management of heart failure and/or associated conditions. An exemplary system may include a baroreflex activation device configured to be implantable proximate a blood vessel of a patient, a measurement device configured to be implantable proximate a blood vessel, and a control system coupled to the baroreflex activation device and the measurement device and in communication with a blood pressure sensing means. The control system is programmed to automatically determine pressure waveform data from the measurement device over a time period of at least a portion of one cardiac cycle, determine a patient physiological parameter based on the pressure waveform data, and compare the patient physiological parameter to a blood pressure measurement taken from the blood pressure sensing means.Type: GrantFiled: October 4, 2012Date of Patent: December 3, 2013Assignee: CVRx, Inc.Inventors: Nadim Yared, Dimitrios Georgakopoulos, Eric Grant Lovett
-
Patent number: 8594794Abstract: The present invention provides systems, devices, and methods for using the same for activating (stimulating) the baroreflex system of a patient using a baroreflex activation system with incrementally changing therapy intensity by sensing/monitoring/interpreting sensed data.Type: GrantFiled: July 17, 2008Date of Patent: November 26, 2013Assignee: CVRx, Inc.Inventors: Robert S. Kieval, Eric Grant Lovett, Alejandro Covalin
-
Patent number: 8401652Abstract: Devices and methods of use are described for detecting and treating an undesirable level of fluid in a pulmonary circulation of a patient. An exemplary system may include an implantable baroreflex activation device including an electrode configured to be implanted proximate a baroreptor within a patient, an implantable sensor configured to provide an indication of a fluid level within the patient, and a control system coupled to the baroreflex activation device and the sensor. The control system may be programmed to automatically detect a level of a fluid in a pulmonary circulation of the patient with the sensor and upon detecting an undesirable level of the fluid in the pulmonary circulation, delivering a therapy via the electrode of the baroreflex activation device to reduce the level of fluid in the pulmonary circulation.Type: GrantFiled: January 27, 2012Date of Patent: March 19, 2013Assignee: CVRx, Inc.Inventors: Dimitrios Georgakopoulos, Eric Grant Lovett
-
Patent number: 8326430Abstract: Devices and methods of use identification, treatment, and/or management of heart failure and/or associated conditions. Methods may include providing a baroreflex therapy system, providing an implantable measurement device proximate a blood vessel of a patient, the implantable measurement device including a plurality of electrodes, determining an impedance of the blood vessel with the implantable measurement device over a time period of at least one cardiac cycle, generating at least one signal representative of a pressure waveform based on the impedance, activating, deactivating or otherwise modulating the baroreflex therapy system to deliver a therapy to treat heart failure based at least in part on the at least one signal representative of the pressure waveform.Type: GrantFiled: June 16, 2009Date of Patent: December 4, 2012Assignee: CVRx, Inc.Inventors: Dimitrios Gerogakopoulos, Eric Grant Lovett
-
Patent number: 8265760Abstract: Devices and methods of use identification, treatment, and/or management of heart failure and/or associated conditions. Methods may include providing a baroreflex therapy system, providing an implantable measurement device proximate a blood vessel of a patient, the implantable measurement device including a plurality of electrodes, determining an impedance of the blood vessel with the implantable measurement device over a time period of at least one cardiac cycle, generating at least one signal representative of a pressure waveform based on the impedance, activating, deactivating or otherwise modulating the baroreflex therapy system to deliver a therapy to treat heart failure based at least in part on the at least one signal representative of the pressure waveform.Type: GrantFiled: June 16, 2009Date of Patent: September 11, 2012Assignee: CVRx, Inc.Inventors: Dimitrios Gerogakopoulos, Eric Grant Lovett
-
Publication number: 20120123506Abstract: Devices and methods of use identification, treatment, and/or management of heart failure and/or associated conditions. Methods may include providing a baroreflex therapy system, providing an implantable measurement device proximate a blood vessel of a patient, the implantable measurement device including a plurality of electrodes, determining an impedance of the blood vessel with the implantable measurement device over a time period of at least one cardiac cycle, generating at least one signal representative of a pressure waveform based on the impedance, activating, deactivating or otherwise modulating the baroreflex therapy system to deliver a therapy to treat heart failure based at least in part on the at least one signal representative of the pressure waveform.Type: ApplicationFiled: January 27, 2012Publication date: May 17, 2012Inventors: Dimitrios Gerogakopoulos, Eric Grant Lovett, Adam Cates
-
Publication number: 20100004714Abstract: Devices and methods of use identification, treatment, and/or management of heart failure and/or associated conditions. Methods may include providing a baroreflex therapy system, providing an implantable measurement device proximate a blood vessel of a patient, the implantable measurement device including a plurality of electrodes, determining an impedance of the blood vessel with the implantable measurement device over a time period of at least one cardiac cycle, generating at least one signal representative of a pressure waveform based on the impedance, activating, deactivating or otherwise modulating the baroreflex therapy system to deliver a therapy to treat heart failure based at least in part on the at least one signal representative of the pressure waveform.Type: ApplicationFiled: June 16, 2009Publication date: January 7, 2010Inventors: Dimitrios Georgakopoulos, Eric Grant Lovett, Adam Cates
-
Publication number: 20090030478Abstract: The present invention provides systems, devices, and methods for using the same for activating (stimulating) the baroreflex system of a patient using a baroreflex activation system with incrementally changing therapy intensity by sensing/monitoring/interpreting sensed data.Type: ApplicationFiled: July 17, 2008Publication date: January 29, 2009Inventors: Robert S. Kieval, Eric Grant Lovett, Alejandro Covalin